Physician profile
Eric M Dyess
NPI 1699783928
$884,751.83
in general payments reported to CMS, 2019-2025
58 companies · $111K in 2025
The $111K reported for 2025 was more than what 98% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $289K · 2020: $88K · 2021: $108K · 2022: $150K · 2023: $86K · 2024: $53K · 2025: $111K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $218K · Food and Beverage: $12K · Travel and Lodging: $11K · Honoraria: $9,105 · Consulting Fee: $499 · Education: $218.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $217,515.00 |
| Food and Beverage | $11,593.57 |
| Travel and Lodging | $10,675.59 |
| Honoraria | $9,105.00 |
| Consulting Fee | $499.12 |
| Education | $217.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $367,140.95 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals Lp | $271,267.19 | 2019-2024 | Farxiga |
| Bayer Healthcare Pharmaceuticals INC. | $81,444.59 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $56,528.90 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $49,050.50 | 2019-2022 | |
| Corcept Therapeutics | $24,257.34 | 2019-2025 | Korlym |
| Amgen INC. | $14,757.33 | 2019-2025 | Evenity, Prolia, Tepezza |
| Abbvie INC. | $12,039.45 | 2019-2025 | Ubrelvy |
| Lilly USA, LLC | $1,397.56 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Abbott Laboratories | $1,038.09 | 2020-2025 | Freestyle Libre 3, Proclaim, Eterna |
| Novartis Pharmaceuticals Corporation | $844.58 | 2022-2025 | |
| Dexcom, INC. | $786.12 | 2021-2025 | Dexcom G6 Transmitter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $447.46 | 2019-2024 | Jardiance, Synjardy, Tradjenta |
| Insulet Corporation | $389.84 | 2019-2025 | Omnipod |
| Esperion Therapeutics, INC. | $379.32 | 2020-2023 | Nexletol |
Show all 58 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Recordati_rare_diseases_inc. | $342.22 | 2020-2024 | Isturisa, Signifor Lar |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $296.41 | 2019-2023 | Cycloset |
| Sanofi-Aventis U.S. LLC | $275.93 | 2019-2025 | |
| Xeris Pharmaceuticals, INC. | $235.22 | 2022-2025 | Recorlev, Gvoke Hypopen |
| Medtronic, INC. | $171.33 | 2023-2025 | Minimed 780g, Intellis Adaptivestim |
| Tandem Diabetes Care, INC. | $125.11 | 2024-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Pfizer INC. | $120.19 | 2019-2025 | |
| Shire North American Group INC | $100.62 | 2019 | |
| Neurocrine Biosciences, INC. | $91.48 | 2024-2025 | |
| Horizon Therapeutics Plc | $83.26 | 2022-2023 | Tepezza |
| Valeritas, INC. | $76.91 | 2019 | |
| Beta Bionics, INC. | $74.55 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Eusa Pharma (US) LLC | $66.78 | 2022 | |
| Janssen Scientific Affairs, LLC | $55.46 | 2019 | |
| Amneal Pharmaceuticals LLC | $54.95 | 2021-2024 | Unithroid |
| Glaxosmithkline, LLC. | $54.26 | 2019-2025 | Shingrix, Arexvy |
| Lifescan, INC. | $54.06 | 2019-2022 | |
| Astellas Pharma US INC | $53.48 | 2023-2025 | Veozah |
| Amryt Pharma Holdings Ltd | $53.28 | 2023 | Mycapssa |
| Kyowa Kirin, INC. | $52.52 | 2023-2025 | Crysvita |
| Ascendis Pharma Endocrinology INC | $49.32 | 2023-2025 | Yorvipath |
| Ibsa Pharma INC. | $49.28 | 2020-2023 | Tirosint, Licart |
| Becton, Dickinson and Company | $45.50 | 2020-2022 | |
| Zealand Pharma US, INC. | $40.42 | 2020-2021 | |
| Arbor Pharmaceuticals, INC. | $36.31 | 2021 | |
| Embecta Corp. | $36.12 | 2023 | Bd Nano 2nd Gen Pen Needle |
| Medtronic Minimed, INC. | $26.53 | 2020 | |
| Nalpropion Pharmaceuticals LLC | $22.68 | 2019 | |
| Eisai INC. | $22.28 | 2019 | |
| Alfasigma USA, INC. | $19.62 | 2020 | |
| Chiesi USA, INC. | $18.66 | 2024 | Mycapssa |
| Vifor Pharma, INC. | $17.38 | 2019 | |
| Tolmar, INC. | $16.51 | 2024 | |
| Nestle Healthcare Nutrition INC. | $16.37 | 2021 | |
| Acella Pharmaceuticals, LLC | $16.26 | 2024 | NP Thyroid 60 |
| Takeda Pharmaceuticals U.S.A., INC. | $15.11 | 2021 | |
| Amarin Pharma, INC. | $15.08 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $15.06 | 2019 | |
| Cequr Corporation | $14.84 | 2024 | Cequr Simplicity |
| Grt US Holding, INC. | $14.55 | 2022 | |
| Ascensia Diabetes Care US INC. | $14.44 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $11.27 | 2020 | |
| Senseonics, Incorporated | $11.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Dyess listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.